NGLFINENSENGL Fine-Chem Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Fri, 27 Jun, 2025 · 14:34 IST

NGL Fine-Chem Limited has informed the Exchange about Credit Rating

Rating Watch NegativeCredit & Debt View source PDFExplain this filing

NGLFINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.5%Reaction day
₹1034.00
prior close
₹1038.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.5%+1.0% vs market
Pharmaceuticals peers, median of 150sector+0.6%+0.9% vs sector

On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 0.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.5+0.5+1.0+0.6+0.9
Next day
+6.5+1.4+5.1+1.4+5.1
2d
+11.9+1.5+10.4+1.4+10.5
3d
+16.2+1.3+15.0+1.0+15.3
4d
+19.1+1.3+17.8+1.0+18.1
5d
+19.4+1.8+17.7+1.6+17.8
1w
+24.5+1.2+23.3+0.6+23.9
15d
+30.9+3.1+27.8+3.8+27.0
1m
+19.1-0.8+20.0+0.9+18.2
2m
+29.1-3.5+32.6-3.7+32.8
3m
+37.3-3.7+41.1-3.6+40.9
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NGL Fine-Chem Limited has received a credit rating from CRISIL. The company has been assigned a long-term rating of CRISIL BBB+ with a negative outlook, while its short-term rating has been reaffirmed at CRISIL A2. The negative outlook on the long-term rating signals that CRISIL sees a possibility of a downgrade in the future if certain conditions are not met. The disclosure was made under SEBI's Listing Obligations Regulations, 2015.

Likely market impact

The negative outlook on the long-term rating is a caution signal for investors, indicating potential stress in the company's financial health or operations. While the current rating remains investment grade, shareholders should monitor the company's financial performance closely, as a further downgrade could affect borrowing costs and investor sentiment.